OBJECTIVE: Few studies have explored the potential association between body mass index (BMI) and non-Hodgkin lymphoma (NHL) according to histologic subtypes, or have evaluated BMI at different periods in the subject's life, and the results of these studies have been inconsistent. SUBJECTS: A population-based, case-control study of 387 patients with NHL and 535 controls conducted in Nebraska between 1999 and 2002. METHODS: Information on usual adult weight, weight at the ages 20-29, 40-49, and 60-69 years, height, physical activity, and other lifestyle factors was collected by telephone interview. A self-administered semi-quantitative food frequency questionnaire was used to collect dietary intake. Risk was estimated by odds ratios (ORs) and 95% confidence intervals (CIs), adjusting for age, total energy intake, physical activity, and other confounding factors. RESULTS: Higher adult BMI was associated with risk of NHL (OR=1.4; 95% CI=0.9-2.0) comparing the obese group (BMI >or= 30.0 kg/m(2)) with the normal weight group (BMI=18.5-24.9 kg/m(2)). The risk was higher for those who were class 2 obese (BMI >or= 35.0 kg/m(2), OR=1.7; 95% CI=1.0-2.9). The positive association was similar among men and women. An excess risk of NHL was associated with high BMI at ages 40-49 years (OR=1.6; 95% CI=1.0-2.5), and to a lesser extent, at ages 20-29 years (OR=1.4; 95% CI=0.8-2.5). Obesity at ages 40-49 years was also associated with a higher risk of small lymphocytic lymphoma (OR=4.5; 95% CI=1.5-13.3), diffuse large B-cell NHL (OR=1.8; 95% CI=0.9-3.9) and follicular NHL (OR=1.8; 95% CI=0.9-3.5). CONCLUSION: Obesity is associated with risk of NHL overall. Obesity at ages 40-49 years is also associated with a higher risk of NHL overall, and particularly small lymphocytic, follicular, and diffuse large B-cell NHL.
OBJECTIVE: Few studies have explored the potential association between body mass index (BMI) and non-Hodgkin lymphoma (NHL) according to histologic subtypes, or have evaluated BMI at different periods in the subject's life, and the results of these studies have been inconsistent. SUBJECTS: A population-based, case-control study of 387 patients with NHL and 535 controls conducted in Nebraska between 1999 and 2002. METHODS: Information on usual adult weight, weight at the ages 20-29, 40-49, and 60-69 years, height, physical activity, and other lifestyle factors was collected by telephone interview. A self-administered semi-quantitative food frequency questionnaire was used to collect dietary intake. Risk was estimated by odds ratios (ORs) and 95% confidence intervals (CIs), adjusting for age, total energy intake, physical activity, and other confounding factors. RESULTS: Higher adult BMI was associated with risk of NHL (OR=1.4; 95% CI=0.9-2.0) comparing the obese group (BMI >or= 30.0 kg/m(2)) with the normal weight group (BMI=18.5-24.9 kg/m(2)). The risk was higher for those who were class 2 obese (BMI >or= 35.0 kg/m(2), OR=1.7; 95% CI=1.0-2.9). The positive association was similar among men and women. An excess risk of NHL was associated with high BMI at ages 40-49 years (OR=1.6; 95% CI=1.0-2.5), and to a lesser extent, at ages 20-29 years (OR=1.4; 95% CI=0.8-2.5). Obesity at ages 40-49 years was also associated with a higher risk of small lymphocytic lymphoma (OR=4.5; 95% CI=1.5-13.3), diffuse large B-cell NHL (OR=1.8; 95% CI=0.9-3.9) and follicular NHL (OR=1.8; 95% CI=0.9-3.5). CONCLUSION: Obesity is associated with risk of NHL overall. Obesity at ages 40-49 years is also associated with a higher risk of NHL overall, and particularly small lymphocytic, follicular, and diffuse large B-cell NHL.
Authors: Geoffrey C Kabat; Mimi Y Kim; Jennifer W Bea; Kerstin L Edlefsen; Lucile L Adams-Campbell; Anneclaire J De Roos; Thomas E Rohan Journal: Cancer Epidemiol Date: 2011-08-04 Impact factor: 2.984
Authors: Yani Lu; Jennifer Prescott; Jane Sullivan-Halley; Katherine D Henderson; Huiyan Ma; Ellen T Chang; Christina A Clarke; Pamela L Horn-Ross; Giske Ursin; Leslie Bernstein Journal: Am J Epidemiol Date: 2009-10-12 Impact factor: 4.897
Authors: James R Cerhan; Zachary S Fredericksen; Alice H Wang; Thomas M Habermann; Neil E Kay; William R Macon; Julie M Cunningham; Tait D Shanafelt; Stephen M Ansell; Timothy G Call; Thomas E Witzig; Susan L Slager; Mark Liebow Journal: Int J Mol Epidemiol Genet Date: 2011-04-05
Authors: Jennifer L Kelly; Zachary S Fredericksen; Mark Liebow; Tait D Shanafelt; Carrie A Thompson; Timothy G Call; Thomas M Habermann; William R Macon; Alice H Wang; Susan L Slager; James R Cerhan Journal: Ann Epidemiol Date: 2012-11-10 Impact factor: 3.797
Authors: Eleanor V Willett; Lindsay M Morton; Patricia Hartge; Nikolaus Becker; Leslie Bernstein; Paolo Boffetta; Paige Bracci; James Cerhan; Brian C-H Chiu; Pierluigi Cocco; Luigino Dal Maso; Scott Davis; Silvia De Sanjose; Karin Ekstrom Smedby; Maria Grazia Ennas; Lenka Foretova; Elizabeth A Holly; Carlo La Vecchia; Keitaro Matsuo; Marc Maynadie; Mads Melbye; Eva Negri; Alexandra Nieters; Richard Severson; Susan L Slager; John J Spinelli; Anthony Staines; Renato Talamini; Martine Vornanen; Dennis D Weisenburger; Eve Roman Journal: Int J Cancer Date: 2008-05-01 Impact factor: 7.396
Authors: Nicholas J Ollberding; Briseis Aschebrook-Kilfoy; Donne Bennett D Caces; Margaret E Wright; Dennis D Weisenburger; Sonali M Smith; Brian C-H Chiu Journal: Carcinogenesis Date: 2012-10-05 Impact factor: 4.944
Authors: Heather A Lankes; Angela J Fought; Andrew M Evens; Dennis D Weisenburger; Brian C-H Chiu Journal: Cancer Causes Control Date: 2008-11-15 Impact factor: 2.506